Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
‘A glimpse of genius’ : what do unpublished stories found in Harper Lee’s apartment tell us about the To Kill a Mockingbird author ?
18/10/2025
Champagne, celebs and artefacts : British Museum hosts first lavish ‘pink ball’ fundraiser
18/10/2025
My cultural awakening : ‘The Specials helped me to stop fixating on death’
18/10/2025
Energy clubs offer chance to reduce electricity bills by up to 30%
18/10/2025
Back on the piste – at 83 : Hilary Bradt and her ‘gang of oldies’ go skiing in Austria
18/10/2025
Nobody Wants This : we can’t get enough of Kristen Bell and Adam Brody’s heartstopping treat of a show
18/10/2025